Various scoring systems evaluating histologic features of chronic hepatitis C treated with interferon

Area of Science:

• Hepatology
• Virology
• Histopathology

Background:

• Standardized scoring systems for evaluating interferon (IFN) therapy in chronic hepatitis C are lacking.
• Histologic changes in liver biopsies are crucial for assessing treatment efficacy.

Purpose of the Study:

• To identify the most effective scoring system for reflecting histologic changes in complete responders to IFN therapy.
• To determine which scoring system can predict the efficacy of IFN therapy in chronic hepatitis C patients.

Main Methods:

• Forty-six chronic hepatitis C patients received 6 months of IFN-alpha therapy.
• Liver biopsy specimens before and after treatment were assessed using Histological Activity Index (HAI), modified HAI, and Scheuer classification.
• Patients were categorized into complete responders (n=15), partial responders (n=24), and nonresponders (n=7).

Main Results:

• Complete responders showed significant improvement in grade and stage with modified HAI and Scheuer classifications.
• The original HAI showed improvement in grade but not stage in complete responders.
• No significant changes were observed in partial responders or nonresponders across all systems.
• Pretreatment piecemeal necrosis scores and Scheuer fibrosis scores predicted nonresponse.

Conclusions:

• The modified HAI and Scheuer classification are useful for evaluating histologic changes in complete responders to IFN therapy.
• Predicting complete response prior to treatment was not feasible with any system.
• Specific histologic features, like piecemeal necrosis and fibrosis, can indicate nonresponse to IFN therapy.